4/18
12:10 pm
crsp
Rating for CRSP
Report
Rating for CRSP
4/18
12:10 pm
crsp
Rating for CRSP
Report
Rating for CRSP
4/11
08:06 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
4/11
06:37 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
4/11
06:37 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
3/6
08:09 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
3/6
08:09 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/26
06:20 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d+" rating to a "c" rating.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d+" rating to a "c" rating.
2/26
10:45 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/26
10:45 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/22
12:38 pm
crsp
Rating for CRSP
Medium
Report
Rating for CRSP
2/22
12:38 pm
crsp
Rating for CRSP
Medium
Report
Rating for CRSP
2/22
11:41 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/22
11:41 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/22
10:41 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/22
10:41 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/22
05:42 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/21
11:39 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/21
11:39 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
2/15
07:17 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
2/15
07:17 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
2/15
06:56 am
crsp
Rating for CRSP
Medium
Report
Rating for CRSP
2/15
06:56 am
crsp
Rating for CRSP
Medium
Report
Rating for CRSP
2/14
04:18 pm
crsp
Crispr Therapeutics initiated with neutral view at Wolfe Research
Medium
Report
Crispr Therapeutics initiated with neutral view at Wolfe Research
2/14
04:18 pm
crsp
Crispr Therapeutics initiated with neutral view at Wolfe Research
Medium
Report
Crispr Therapeutics initiated with neutral view at Wolfe Research